Agios Pharmaceuticals, Inc.

Home » Agios Pharmaceuticals, Inc.

Secondary

Agios Pharmaceuticals, Inc.

Agios is focused on discovering and developing novel investigational medicines to treat cancer and rare genetic diseases through scientific leadership in the field of cellular metabolism.

Symbol

AGIO

Last Closing Price
$68.15

Shares
5,700,000

Effective Date
January 19, 2018

Underwriters
J.P. Morgan, Goldman Sachs, Cowen & Co.

To view the prospectus for Agios Pharmaceuticals, Inc., or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253